TOI Analyst Price Targets - Benzinga

SPY775.28+0.06%QQQ756.77+0.08%BTC/USD85,828.00−0.79%DIA512.51+0.08%GLD379.51−0.01%TLT77.19+0.10%

TOI

TOINasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

TOI Analyst Price Targets - Benzinga

TOI Analyst Price Targets

Wall Street analyst price targets and consensus rating for TOI (TOI).

Price Target Range — 6 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$7

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 9, 2026	BTIG	David Larsen	PT Raise	Buy	$8→$9
Jul 6, 2026	Lake Street	Ben Haynor	Initiate	Buy	$10
Jun 17, 2026	Needham	Matthew Shea	PT Raise	Buy	$5→$7
Jun 8, 2026	BTIG	David Larsen	PT Raise	Buy	$7→$8
Mar 13, 2026	B. Riley Securities	Yuan Zhi	PT Raise	Buy	$6→$8
Mar 13, 2026	Needham	Matthew Shea	Maintained	Buy	$5
Mar 9, 2026	Needham	Matthew Shea	Maintained	Buy	$5
Mar 9, 2026	BTIG	David Larsen	Maintained	Buy	$7
Nov 25, 2025	Needham	Matthew Shea	Initiate	Buy	$5
Oct 21, 2025	BTIG	David Larsen	Maintained	Buy	$7
Jul 16, 2025	B. Riley Securities	Yuan Zhi	Initiate	Buy	$6
Feb 26, 2024	Jefferies	Jack Slevin	Assumes	Buy	$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $9

BTIG analyst David Larsen maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $10

Lake Street analyst Ben Haynor initiates coverage on Oncology Institute (NASDAQ:TOI) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Oncology Institute, Raises Price Target to $7

Needham analyst Matthew Shea maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $5 to $7.

Benzinga Newsdesk

Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analyst ratings page.

Avi Kapoor

PRO
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $8

BTIG analyst David Larsen maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Oncology Institute, Raises Price Target to $8

B. Riley Securities analyst Yuan Zhi maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $6 to $8.

Benzinga Newsdesk